Abeona Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Abeona Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Abeona Therapeutics Inc
Rating: 2.73900
Author: Trendlyne DVM scores

about

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene the...

5.77 0.12 (2.12%)

44.25% Gain from 52W Low

1.1M

XNAS Volume

XNAS 18 Jun, 2026 5:30 PM (EDT)

Not Eligible

Mid Valuation

43.0 / 100

Technically Moderately Bullish

66.6 / 100

1Yr Price target upside is 242%

7 analysts

Abeona Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Abeona Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene the...

44.25% Gain from 52W Low

SWOT Analysis

Abeona Therapeutics Inc Live Price Chart